findmyKOL

Sandra Lewis, MD

Basic profile

Legacy Health

ORCID↗NPI↗
✓ Full record
RegionPortland, OR · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sandra Lewis is a Cardiology physician affiliated with Legacy Health. OpenAlex indexes 35 publications with 2,395 citations (h-index 15).

Overview

Scholarship

indexed output and impact (OpenAlex)
35publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,395citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2222 NW Lovejoy St
Suite 606
Portland, OR 972103033

Telephone

503-229-7554

Registry record last updated 21 Jul 2022.

View the NPPES registry record

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    80.5%
    Statin20.4%
    Rosuvastatin Calcium65%Atorvastatin Calcium31%Pravastatin Sodium4%
    Part D<11 patients
    Beta blocker16.7%
    Metoprolol Succinate70%Carvedilol17%Atenolol7%Metoprolol Tartrate6%
    Part D<11 patients

    + 11 more classes in this area

  • Blood & clotting

    14%
    Factor Xa inhibitor10.1%
    Eliquis94%Xarelto6%
    Part D<11 patients
    P2Y12 inhibitor3.2%
    Clopidogrel100%
    Part D≥17 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    5.5%
    Potassium supplement2.6%
    Potassium Chloride100%
    Part D≥15 patients
    SGLT2 inhibitor2.3%
    Farxiga62%Jardiance38%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”